Literature DB >> 18040748

A better method for preventing infection of percutaneous endoscopic gastrostomy.

Chao-Hung Kuo1, Huang-Ming Hu, Pei-Yun Tsai, Chen-Ju Liu, Fang-Jung Yu, Ko Chang, Yong-Sang Pan, Angela Chen, Chang-Ming Jan, Wen-Ming Wang, Deng-Chyang Wu.   

Abstract

BACKGROUND: Percutaneous endoscopic gastrostomy (PEG) has been widely used to maintain enteral nutrition in dysphagic patients. Local and occasional life-threatening systemic infections are still the most common complications, and the major infection source may be nosocomial flora. The effect of antibiotic prophylaxis on reducing peristomal infection is popularly accepted. However, it is accompanied with a possible risk of increasing antibiotic resistance. AIM: This study attempted to determine whether 14-day discharge before PEG could reduce the rate of peristomal infection.
MATERIALS AND METHODS: Fifty patients who had received PEG in our hospital were included in this study and followed for at least 6 months (except for those patients who died during this period). Patients were separated into two groups randomly. Twenty-five patients received PEG during in-hospitalization (group A). The other 25 patients received PEG until discharge at least for 14 days (group B). The most frequent indication for PEG insertion was the neurological condition. Risk factors for peristomal infection were analyzed statistically using logistic regression and expressed by odds ratios. Every possible factor was analyzed by chi-square test or Student's t test. RESULT: Our data showed that group A had a higher peristomal infection rate than group B (32 vs 8%) (p < 0.05). Group A also showed more need of antibiotics. The risk factors related to peristomal infection were group A and lower albumin. The total rate of 30-day mortality was 4%. DISCUSSION: When compared with previous data, our study showed a similar infection rate in group A, a lower infection rate in group B, and a lower 30-day mortality rate. This meant that one period of discharge could reduce the peristomal infections caused by colonized bacteria. It also decreased the need of using antibiotics and might avoid the possible adverse consequence of promoting bacterial resistance, which is an alarming and growing problem in hospital practice.
CONCLUSION: We suggest that a 14-day grace period after discharge, before PEG insertion, may decrease peristomal infection rate, length of hospital stay after PEG, and the need for antibiotics. This is suitable for moral and ethical considerations.

Entities:  

Mesh:

Year:  2007        PMID: 18040748     DOI: 10.1007/s11605-007-0390-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  Mortality with percutaneous endoscopic gastrostomy.

Authors:  J P Grant
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

2.  Antibiotic prophylaxis in percutaneous endoscopic gastrostomy.

Authors:  T M Sturgis; W Yancy; J C Cole; D D Proctor; B S Minhas; S P Marcuard
Journal:  Am J Gastroenterol       Date:  1996-11       Impact factor: 10.864

Review 3.  Complications of percutaneous endoscopic gastrostomy.

Authors:  G D Schapiro; S A Edmundowicz
Journal:  Gastrointest Endosc Clin N Am       Date:  1996-04

4.  Decision-making and outcomes for percutaneous endoscopic gastrostomy: a pilot study.

Authors:  G M Van Rosendaal; M J Verhoef; S R Mace; T D Kinsella
Journal:  J Clin Gastroenterol       Date:  1997-03       Impact factor: 3.062

5.  Percutaneous endoscopic gastrostomy by the "pull" and "introducer" methods.

Authors:  M Deitel; M Bendago; E H Spratt; C J Burul; T B To
Journal:  Can J Surg       Date:  1988-03       Impact factor: 2.089

6.  Complications and outcome of percutaneous endoscopic gastrostomy in different patient groups.

Authors:  M A Chowdhury; R Batey
Journal:  J Gastroenterol Hepatol       Date:  1996-09       Impact factor: 4.029

7.  Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy.

Authors:  S K Jonas; S Neimark; A P Panwalker
Journal:  Am J Gastroenterol       Date:  1985-06       Impact factor: 10.864

8.  Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial.

Authors:  N K Jain; D E Larson; K W Schroeder; D D Burton; K P Cannon; R L Thompson; E P DiMagno
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

9.  How are decisions made about the use of percutaneous endoscopic gastrostomy for long-term nutritional support?

Authors:  G M Van Rosendaal; M J Verhoef; T D Kinsella
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

10.  Outcome of percutaneous endoscopic gastrostomy (PEG): comparison of two policies in a 4-year experience.

Authors:  Galia Abuksis; Meli Mor; Shlomit Plaut; Gerald Fraser; Yaron Niv
Journal:  Clin Nutr       Date:  2004-06       Impact factor: 7.324

View more
  3 in total

1.  Airway infection predisposes to peristomal infection after percutaneous endoscopic gastrostomy with high concordance between sputum and wound isolates.

Authors:  Chiao-Hsiung Chuang; Kuei-Hsiang Hung; Jen-Ru Chen; Chiung-Yu Chen; Ai-Wen Kao; Wei-Lun Chang; Jiunn-Jong Wu; Bor-Shyang Sheu
Journal:  J Gastrointest Surg       Date:  2009-10-09       Impact factor: 3.452

2.  Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: a multicenter, retrospective study.

Authors:  Changhyun Lee; Jong Pil Im; Ji Won Kim; Seong-Eun Kim; Dong Yup Ryu; Jae Myung Cha; Eun Young Kim; Eun Ran Kim; Dong Kyung Chang
Journal:  Surg Endosc       Date:  2013-05-04       Impact factor: 4.584

3.  Percutaneous endoscopic gastrostomy site infections-Incidence and risk factors.

Authors:  Kayal Vizhi; Harshavardhan B Rao; Rama P Venu
Journal:  Indian J Gastroenterol       Date:  2018-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.